{"product_id":"bcl2l11-antibody-sc-f2855","title":"Bim Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eBCL2L11 is a target of interest in many antibody-based workflows. Bim (Bcl-2-interacting mediator of cell death) is a BH3-only pro-apoptotic protein essential for initiating the intrinsic apoptotic pathway by activating Bax and Bak, leading to mitochondrial outer membrane permeabilization and cytochrome c release. Bim contains a BH3 domain required for binding anti-apoptotic Bcl-2 family proteins like Bcl-xL and Mcl-1. Depending on the literature source, BCL2L11 may also be discussed as Bim.\u003c\/p\u003e\u003cp\u003eReported cellular context includes membrane and mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following BCL2L11 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eBCL2L11 is commonly interpreted in the context of cancer and apoptosis research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans membrane and mitochondrion, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between membrane and mitochondrion across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003eseparation of survival-associated changes from stress or death-associated readouts\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for BCL2L11. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in BCL2L11 reflect biology rather than handling. When interpreting BCL2L11, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep BCL2L11 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577976168793,"sku":"F2855-20UL","price":139.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577976201561,"sku":"F2855-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577976234329,"sku":"F2855-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2855-IF.png?v=1773600753","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/bcl2l11-antibody-sc-f2855","provider":"Absource Diagnostics","version":"1.0","type":"link"}